Drugs For Treatment Of Rare Diseases Propel Demand Of Andersen-Tawil Syndrome Market

In its recently added report by Fact.MR has provided unique insights about Andersen-Tawil Syndrome Market for the given period. One of the main objectives of this report is to categorize the various dynamics of the market and to offer the latest updates such as mergers and acquisitions, various technological developments, new entrants in the market, which make an impact on different segments.

The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with a detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.


Andersen-Tawil syndrome is considered a rare form of periodic paralysis and is a type of long QT syndrome. The Andersen- tawil syndrome leads to changes in heart rhythm (arrhythmia). Episodes of muscle weakness and developmental abnormalities is also observed in patients with Andersen-tawil syndrome.

Head, face, and limbs are primarily affected in the physical abnormalities associated with this condition. Andersen-Tawil syndrome is caused by mutations in the KCNJ2 gene in some cases.

While in other cases, the associated gene is unknown. The KCNJ2 gene mutation can be inherited in an autosomal dominant manner and occur randomly for unknown reasons (sporadically).

It is estimated that the patients suffering from diseases such as diabetes and cardiovascular diseases are at a higher risk to develop andersen-tawil syndrome. Therefore, the rise in prevalence of these diseases may also lead a rise in the number Andersen-Tawil Syndrome cases.


Research Coverage

This report segments the functional proteins market based on type, source, form, application and region. In terms of insights, this research report focuses on various levels of analyses—competitive landscape, pricing insights, end-use analysis, and company profiles—which together comprise and discuss the basic views on the emerging & high-growth segments of the functional proteins market, high-growth regions, countries, industry trends, drivers, restraints, opportunities, and challenges.

Critical insights enclosed in the report:

    • In-depth assessment of the leading market players in the Andersen-Tawil Syndrome market
    • The regional analysis of the different market segments and sub-segments
    • Recent mergers, acquisitions, collaborations, partnerships, and R&D activities.
  • SWOT analysis of the prominent players in the Andersen-Tawil Syndrome market
  • Y-o-Y revenue growth of the Andersen-Tawil Syndrome market during the forecast period

Andersen-Tawil Syndrome Market: Key players

Some of the players identified in the Andersen-Tawil Syndrome Market include:

  • Teva Pharmaceuticals Ltd.
  • Zydus Pharmaceuticals, Inc.
  • Sun Pharmaceuticals Industries Ltd.
  • Advanz Pharmaceticals
  • Novartis AG
  • Mylan N.V.

Andersen-Tawil Syndrome Market market: segmented

Tentatively, the global Andersen-Tawil Syndrome Market has been segmented on the basis of disease type, drug-class and distribution channel.

Based on disease type, the global Andersen-Tawil Syndrome Market is segmented as:

  • Type 1
  • Type 2

Based on Drug-class, the global Andersen-Tawil Syndrome Market is segmented as:

  • Carbonic anhydrate Inhibitors
  • Acetazolamide
  • Dichlorpenamide
  • Antiarrhythmic drugs
  • Amiodarone
  • Flecainide
  • Beta-Blockers
  • Atenolol

Based on distribution channel, the global Andersen-Tawil Syndrome Market is segmented as:

  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy

Reasons to buy this report

  • To get a comprehensive overview of the Andersen-Tawil Syndrome market
  • To gain wide-ranging information about the top players in this industry, their product portfolio details, and the key strategies adopted by them
  • To gain insights about the major countries/regions, in which the Andersen-Tawil Syndrome market is flourishing


Andersen-Tawil Syndrome Market: OverviewBased on disease type, type 1 Anderson-Tawil syndrome is expected to hold a larger share in the Anderson-tawil market. As type 1 is caused by a known KCNJ2 gene mutation making it easier to identify and commence the treatment of the disease.In the drug class segment, carbonic anhydrate inhibitors and beta blockers are expected to dominate the Anderson-tawil syndrome market during the forecast period.

Andersen-Tawil Syndrome Market: Regional-Wise OutlookGeographically, the Andersen-Tawil Syndrome Market is segmented into seven regions viz. South Asia, East Asia, Europe, Latin America, North America, Oceania and Middle East and Africa.North America is expected to dominate the market owing to high healthcare expenditure. The availability of state of the art healthcare facilities in this region is also expected to drive the growth of the Andersen-Tawil Syndrome Market. The availability of funds for research and government support are factor that makes Europe the second largest market for Andersen-Tawil Syndrome.

South Asia is expected to experience fastest growth in the Andersen-Tawil Syndrome market. This is due to improving healthcare infrastructure along with a rise in the no. of cases suffering from the disease.

In addition, rising awareness may also help to drive the growth of the Andersen-Tawil Syndrome market at a faster rate in this region. The developing private healthcare in countries like India may also lead to contributing towards the growth of Andersen-Tawil Syndrome market.

However, limited technological advancement, slow economic growth and absence of major players in the Middle East and Africa will lead to limited growth of Andersen-Tawil Syndrome Market in this region.

Why Purchase From Fact.MR?

  • Customized market reports as per the clients’ requirement
  • Rich experience in curating market reports for clients from different industrial domains
  • Round the clock customer service for clients in different time zones
  • Over 300+ queries addressed every day
  • Catering to over 700+ clients each year

Explore Fact.MR’s Coverage on the Healthcare Domain: 

Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.

Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates